Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bc50c0b06df6f49a3f48c8e6d6c0e193c> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bc50c0b06df6f49a3f48c8e6d6c0e193c NCIT_P378 "NCI" @default.
- Bc50c0b06df6f49a3f48c8e6d6c0e193c type Axiom @default.
- Bc50c0b06df6f49a3f48c8e6d6c0e193c annotatedProperty IAO_0000115 @default.
- Bc50c0b06df6f49a3f48c8e6d6c0e193c annotatedSource NCIT_C516 @default.
- Bc50c0b06df6f49a3f48c8e6d6c0e193c annotatedTarget "A glycosphingolipid antigen expressed by a variety of human cancer cells. GM2 containing vaccines have been shown to elicit antibodies production in melanoma patients without deleterious effects associated with an immune response to GM2. Mutations in at least 1 of 3 recessive genes: HEXA, HEXB, and GM2A cause defects in GM2 catabolism, leading to lysosomal lipid storage disorders that manifest primarily as neurodegenerative diseases, including Tay-Sachs and Sandhoff Disease." @default.